Research ArticleArticle
Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis
Sijia Chen, Iris C. Blijdorp, Leonieke J.J. van Mens, Rowann Bowcutt, Talia E. Latuhihin, Marleen G.H. van de Sande, Stevan Shaw, Nataliya G. Yeremenko and Dominique L.P. Baeten
The Journal of Rheumatology January 2020, jrheum.190571; DOI: https://doi.org/10.3899/jrheum.190571
Sijia Chen
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Iris C. Blijdorp
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Leonieke J.J. van Mens
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Rowann Bowcutt
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Talia E. Latuhihin
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Marleen G.H. van de Sande
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Stevan Shaw
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Nataliya G. Yeremenko
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
Dominique L.P. Baeten
Dr. Baeten is supported by a VICI grant from the Netherlands Organization for Scientific Research, a consolidator grant from the European Research Council, and grants from the Dutch Arthritis Foundation Reumafonds. S. Chen, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA; I.C. Blijdorp, BSc, T.E. Latuhihin, BSc, N.G. Yeremenko, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, and Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; L.J. van Mens, MD, PhD, M.G. van de Sande, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, the Netherlands; R. Bowcutt, PhD, S. Shaw, PhD, New Medicines, UCB Pharma, Slough, UK; D.L. Baeten, MD, PhD, Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center, University of Amsterdam, Amsterdam, Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands, and New Medicines, UCB Pharma, Slough, UK. S. Chen, I.C. Blijdorp, N.G. Yeremenko, and D.L. Baeten contributed equally to this report. Address correspondence to Dr. D. Baeten, Clinical Immunology and Rheumatology, F4-105, Amsterdam University Medical Center/University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. Email: d.l.baeten@amc.uva.nl. Accepted for publication December 10, 2019.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis
Sijia Chen, Iris C. Blijdorp, Leonieke J.J. van Mens, Rowann Bowcutt, Talia E. Latuhihin, Marleen G.H. van de Sande, Stevan Shaw, Nataliya G. Yeremenko, Dominique L.P. Baeten
The Journal of Rheumatology Jan 2020, jrheum.190571; DOI: 10.3899/jrheum.190571
Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis
Sijia Chen, Iris C. Blijdorp, Leonieke J.J. van Mens, Rowann Bowcutt, Talia E. Latuhihin, Marleen G.H. van de Sande, Stevan Shaw, Nataliya G. Yeremenko, Dominique L.P. Baeten
The Journal of Rheumatology Jan 2020, jrheum.190571; DOI: 10.3899/jrheum.190571